OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 73 filers reported holding OPHTHOTECH CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $44,000 | -58.1% | 36,858 | -17.5% | 0.00% | -62.5% |
| Q3 2018 | $105,000 | -40.7% | 44,692 | -31.1% | 0.01% | -38.5% |
| Q2 2018 | $177,000 | -67.7% | 64,902 | -67.6% | 0.01% | -68.3% |
| Q1 2018 | $548,000 | -55.6% | 200,082 | -49.4% | 0.04% | -54.9% |
| Q4 2017 | $1,233,000 | -2.5% | 395,443 | -11.9% | 0.09% | +5.8% |
| Q3 2017 | $1,265,000 | -30.4% | 448,841 | -36.8% | 0.09% | -35.3% |
| Q2 2017 | $1,818,000 | -55.2% | 710,284 | -36.0% | 0.13% | -53.0% |
| Q1 2017 | $4,062,000 | -34.3% | 1,109,961 | -13.2% | 0.28% | -33.6% |
| Q4 2016 | $6,179,000 | – | 1,279,451 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
| Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
| Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
| JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
| AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
| Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
| IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
| Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
| Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
| WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |